MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$670,812K
Cash and cash
equivalents
$85,721K
Prepaid expenses and
other current assets
$21,248K
Total current assets
$777,781K
Total assets
$777,781K
Total liabilities,
convertible preferred stock...
$777,781K
Total convertible
preferred stock and...
$715,236K
Total liabilities
$62,545K
Accumulated deficit
-$1,127,635K
Additional paid-in capital
$1,686,167K
Total current
liabilities
$58,685K
Non-current cvr liability
$3,860K
Preferred stock-Series
ANon Voting...
$146,425K
Preferred stock-Series
BNon Voting...
$9,395K
Accumulated other
comprehensive income
$869K
Common stock, 0.0001
par value...
$15K
Accrued and other
current liabilities
$26,947K
Cvr liability
$22,820K
Accounts
payable-Nonrelated Party
$8,904K
Related party accounts
payable-Related Party
$14K
Back
Back
Balance Sheet
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)